“Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units”, J. Anal. Oncol., vol. 5, no. 1, pp.  42–46, Jan. 2016, doi: 10.6000/1927-7229.2016.05.01.6.